AMP

What AMP does

AMP Alternative Medical Products GmbH is a German medical cannabis importer and wholesale distributor headquartered in Erfurt. The company sources EU-GMP certified cannabis flower and extracts from producers in Canada, the Netherlands, Australia, Denmark, and Austria, and routes them into German pharmacies through a multi-channel go-to-market anchored by an exclusive distribution agreement with CC Pharma, an Aphria subsidiary that reaches more than 13,000 pharmacies across Germany.

The company's core operational assets are its regulatory licenses: a BtMG narcotics import permit, a §52a AMG wholesale authorization, an irradiation license, and EU-GMP certification, together with a proprietary supplier qualification protocol used to onboard international producers. AMP has expanded beyond regulated pharmacy-channel medical cannabis into consumer products through the CANAVEX CBD brand and the HANAFSAN CBD cosmetics line. A national sales team is being built out across all 16 German states to complement wholesale distribution and reduce single-channel dependence.

AMP generates revenue primarily through wholesale gram-level pricing of imported cannabis products to pharmacies (directly and via CC Pharma) and, more recently, through retail and DTC sales of its CANAVEX and HANAFSAN consumer lines. The company also pursues adjacent revenue and ecosystem levers including clinical study partnerships (e.g., WaldhausKlinik) and statutory health insurance reimbursement work for cannabinoid therapy. AMP was taken private in December 2022 through an acquisition by Swiss holding company Essence Investment AG, ending its earlier Canadian dual listing and consolidating ownership under a single strategic investor.

Name

AMP

Legal name

AMP Alternative Medical Products GmbH

Website

https://amp-eu.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

AMP is a German medical cannabis importer and wholesale distributor headquartered in Erfurt that sources EU-GMP certified cannabis from producers in Canada, the Netherlands, Australia, Denmark, and Austria and distributes it to German pharmacies via CC Pharma and its own national sales team.

Ownership category

akta.pro rank

Headquarters

HQ city

Erfurt

HQ country

Germany

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Cannabis Import and Distribution: AMP imports EU-GMP certified medical cannabis products from international suppliers (Canada, Netherlands, Australia, Denmark, Austria) and sells directly to pharmaceutical distributors or pharmacies in Germany. Revenue is generated through product sales at negotiated prices, with distributors handling the 'last mile' delivery to over 13,000 pharmacies across Germany. The company generates revenue from the margin between import purchase price and sale price to distributors/pharmacies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

AMP is a licensed German importer and distributor of EU-GMP certified medical cannabis. The company sources medical cannabis flowers and extracts from international producers in Canada, the Netherlands, Australia, Denmark, and Austria, qualifies and registers the products with German authorities (BfArM), and distributes them to over 13,000 German pharmacies through pharmaceutical wholesalers such as CC Pharma. AMP also markets its own CBD sub-brands CANAVEX and HANAFSAN through German pharmacies.

Product overview

AMP operates as a licensed German importer and distributor of EU-GMP certified medical cannabis products. The company imports medical cannabis flowers and extracts from international licensed producers (Canada, Netherlands, Denmark, Australia) and distributes them to German pharmacies through distribution partnerships. AMP's portfolio includes proprietary sub-brands CANAVEX (CBD wellness products) and HANAFSAN (CBD cosmetics), alongside branded medical cannabis products from suppliers like Aphria, Bedrocan, Little Green Pharma, and Schroll Medical. The company holds EU-GMP certification and required German import licenses for controlled substances.

Differentiator

Problem solved

Functional benefit

Brands

• CANAVEX: CBD brand introduced by AMP for distribution through German pharmacies without prescription
• HANAFSAN

Products and services

• Medical Cannabis Import and Distribution Import and distribution of EU-GMP certified medical cannabis flowers, extracts, and novel dosage forms sourced from licensed international producers (Canada, Netherlands, Denmark, Australia, Austria). Sold to pharmaceutical wholesalers and pharmacies in Germany for dispensing to patients with medical prescriptions.
• CANAVEX CBD Brand Proprietary CBD wellness brand introduced by AMP for sale through German pharmacies without prescription.
• HANAFSAN CBD Cosmetics Approved CBD cosmetic products distributed in Germany through a supply partnership with Dr. Feurstein Medical Hemp GmbH.

Quantifiable outcome

• Supplying growing German market projected to exceed 1 million patients by 2024

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Nine partnerships are on record, tiered core and minor.

• Tilray (formerly Aphria)coreGTM or Marketing Partner · 28 September 2021AMP became exclusive marketing partner for Tilray/Aphria branded medical cannabis products in Germany for all products imported into or cultivated in Germany. This partnership positions AMP as the exclusive marketing representative for Aphria products in the German market.
• WaldhausKlinik DeuringenminorStrategic or Co-development Partner · 13 September 2021Clinical study partnership to investigate the effects of medical cannabis. WaldhausKlinik is a non-profit acute clinic for Internal Medicine in Bavaria (Stadtbergen, Germany).
• Dr. Feurstein Medical Hemp GmbH (HANAFSAN)minorChannel Partner/ Reseller/ Distributor · 12 May 2021Supply agreement for approved CBD cosmetic products under the HANAFSAN brand for distribution in German pharmacies without prescription. Austrian manufacturer of pharmaceutical CBD hemp products.
• Schroll Medical ApScoreChannel Partner/ Reseller/ Distributor · 5 November 2020Long-term supply agreement with Danish medical cannabis manufacturer. Denmark is developing pharmaceutical-quality cultivation standards for export to Germany.
• Little Green PharmaminorChannel Partner/ Reseller/ Distributor · 22 October 2020Supply agreement adding medical cannabis extracts from Australian manufacturer Little Green Pharma to AMP's product portfolio.
• Eve & Co.coreChannel Partner/ Reseller/ Distributor · 11 August 2020Supply agreement for EU-GMP certified medical cannabis flowers from Canada. Eve & Co. operates a 1,000,000 square foot greenhouse facility in Strathroy, Ontario and received EU-GMP certification in March 2020. First large import to Germany expected with 50-100 kg, followed by monthly imports of up to 100 kg starting 2021.
• CC Pharma GmbHcoreChannel Partner/ Reseller/ Distributor · 15 October 2019Non-exclusive 4-year distribution agreement. CC Pharma is a 100% subsidiary of Aphria Inc. and a leading pharmaceutical distributor serving over 13,000 pharmacies across Germany. CC Pharma achieved 2018 revenue of approximately 262 million EUR with EBITDA of approximately 10.5 million EUR. Founded in 1999, employs over 230 people with operations in Germany, Denmark, Poland, and Czech Republic.
• Pure Life Cannabis CorporationminorChannel Partner/ Reseller/ Distributor · 7 February 2019Non-binding MOU for supply of up to 1,200 kg of medical cannabis flowers per year. Pure Life is building a Phase 1 facility with approximately 2,000 kg annual EU-GMP cannabis flower production capacity and 8,000 kg for Canadian market products.
• Bedrocan InternationalcoreChannel Partner/ Reseller/ DistributorDutch government-affiliated medical cannabis supplier. AMP imports Bedrocan branded products from the Netherlands. The Office for Medical Cannabis (OMC) manages distribution of medical cannabis products from the Netherlands.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Sanity Group: Berlin-based German cannabis company with medical cannabis cultivation and distribution operations. Comparable as a German-focused cannabis company targeting the pharmacy and patient market with similar regulatory profile.
• Demecan: German medical cannabis producer and distributor operating under similar EU-GMP and BfArM licensing framework. Directly comparable as a domestic German player in the same medical-cannabis import/distribution and pharmacy supply chain.
• Cannamedical Pharma: German medical cannabis wholesaler supplying pharmacies across Germany. Directly comparable as a licensed importer/wholesaler operating in the same regulatory and customer environment as AMP.
• CannaCare Health: German medical cannabis distributor focused on pharmacy supply and patient services. Comparable as a B2B distributor serving the same regulated German pharmacy channel.
• Bloomwell Group: German medical cannabis platform focused on pharmacy distribution and patient access. Comparable business model as a B2B distributor of medical cannabis products to German pharmacies.

Broad incumbents

• Aurora Cannabis: Canadian cannabis major with EU-GMP-certified production and European medical cannabis distribution including into Germany. Comparable as a large-scale supplier/competitor in the same cross-border medical cannabis trade.
• Canopy Growth: Global cannabis major operating Spectrum Therapeutics in Germany, selling medical cannabis through German pharmacies. Comparable as a large incumbent with overlapping Germany-focused medical cannabis distribution.
• STADA Arzneimittel AG: Major German pharmaceutical company that has entered medical cannabis distribution via partnerships. Comparable as a broad incumbent using existing pharma/pharmacy channels to distribute cannabis products.
• Tilray Brands: Global cannabis leader whose Aphria subsidiary owns CC Pharma (AMP's distribution partner) and is itself a major EU-GMP-certified supplier into Germany. Both partner and broad peer through its German medical cannabis footprint.

Regional players

• Stenocare: Danish medical cannabis producer and distributor supplying European markets including Germany. Comparable as a neighboring EU producer/distributor using similar EU-GMP framework, though operating from a different home geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/AMP_Cannabis
• YouTubeyoutube.com/channel/UCHDo-R0wuz-UZmwZ-Pj5WHg
• Facebookfacebook.com/AMPGCG
• LinkedInlinkedin.com/company/ampgermancannabisgroup
• Instagraminstagram.com/ampgcg

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AMP